Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04554888Completed
Randomised, single-blind trial of doxepin in pruritus (2 arms), sponsored by Aalborg University. Primary endpoints: Superficial blood perfusion at 15 minutes, Itch intensity at 15 minutes and 2 more. Started Mar 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04554888.